| Use of DPP4 inhibitors and GLP-1 receptor agonists and risk of intestinal obstruction: Scandinavian cohort study P Ueda, V Wintzell, M Melbye, B Eliasson, J Söderling, S Gudbjörnsdottir, ... Clinical Gastroenterology and Hepatology 22 (6), 1226-1237. e14, 2024 | 3 | 2024 |
| A plasma protein-based risk score to predict hip fractures TR Austin, M Nethander, HA Fink, AE Törnqvist, DI Jalal, P Buzkova, ... Nature aging, 1-12, 2024 | | 2024 |
| Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study B Pasternak, V Wintzell, A Hviid, B Eliasson, S Gudbjörnsdottir, ... bmj 385, 2024 | 1 | 2024 |
| Association of inflammatory markers with incident heart failure or cancer in the HUNT3 and Health ABC population studies E Bertero, L Carmisciano, C Jonasson, J Butler, C Maack, P Ameri European Journal of Preventive Cardiology, zwae089, 2024 | 2 | 2024 |
| Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development AM Shah, PL Myhre, V Arthur, P Dorbala, H Rasheed, LF Buckley, ... Nature communications 15 (1), 528, 2024 | | 2024 |
| Large-scale circulating proteome association study (CPAS) meta-analysis identifies circulating proteins and pathways predicting incident hip fractures TR Austin, HA Fink, DI Jalal, AE Törnqvist, P Buzkova, JI Barzilay, T Lu, ... Journal of Bone and Mineral Research, zjad011, 2024 | 3 | 2024 |
| Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A scandinavian cohort study A Engström, V Wintzell, M Melbye, H Svanström, B Eliasson, ... Hepatology, 10.1097, 2023 | 8 | 2023 |
| Glucagon-like Peptide 1 Receptor Agonist Use and Risk of Thyroid Cancer: Scandinavian Cohort Study C Jonasson | | 2023 |
| OC 63.1 The Plasma Proteome and Risk of Venous Thromboembolism (VTE) S Brækkan, A Onsaker, T Nøst, V Morelli, W Tang, W Guan, A Folsom, ... Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
| Sodium–Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study A Engström, V Wintzell, M Melbye, A Hviid, B Eliasson, S Gudbjörnsdottir, ... Diabetes care 46 (2), 351-360, 2023 | 14 | 2023 |
| Sodium-glucose co-transporter 2 inhibitor treatment and risk of atrial fibrillation: Scandinavian cohort study A Engstrom, V Wintzell, M Melbye, A Hviid, B Eliasson, S Gudbjornsdottir, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 97-97, 2022 | 2 | 2022 |
| Association of Glucagon-Like Peptide-1 Receptor Agonists with Serious Liver Events: A Scandinavian Cohort Study A Engström, V Wintzell, M Melbye, H Svanström, B Eliasson, ... Available at SSRN 4411413, 2022 | | 2022 |
| Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population … S Halvorsen, JA Smith, F Söderdahl, M Thuresson, O Solli, M Ulvestad, ... BMC Primary Care 23 (1), 214, 2022 | 1 | 2022 |
| Characteristics, treatment patterns, and residual cardiovascular risk of patients with a first acute myocardial infarction: A nationwide population‐based cohort study in Norway NG Oberprieler, B Farahmand, J Cameron, G Brobert, C Jonasson, D Atar Fundamental & Clinical Pharmacology 36 (3), 563-571, 2022 | 1 | 2022 |
| Sodium–glucose cotransporter 2 inhibitors and risk of bladder and renal cancer: Scandinavian cohort study P Ueda, H Svanström, A Hviid, B Eliasson, AM Svensson, S Franzén, ... Diabetes Care 45 (5), e93-e96, 2022 | 10 | 2022 |
| A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk SA Williams, R Ostroff, MA Hinterberg, J Coresh, CM Ballantyne, ... Science translational medicine 14 (639), eabj9625, 2022 | 45 | 2022 |
| The comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A Scandinavian cohort study P Ueda, V Wintzell, E Dahlqwist, B Eliasson, AM Svensson, S Franzén, ... Diabetes, Obesity and Metabolism 24 (3), 473-485, 2022 | 16 | 2022 |
| Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation OCW Rutherford, C Jonasson, W Ghanima, F Söderdahl, S Halvorsen Heart 108 (5), 345-352, 2022 | 38 | 2022 |
| 506 Role of inflammation and comorbidities in the association between heart failure and incident cancer in the HUNT3 cohort E Bertero, L Carmisciano, C Jonasson, C Maack, P Ameri European Heart Journal Supplements 23 (Supplement_G), suab130, 2021 | | 2021 |
| Progress Towards a Proteomic Surrogate Endpoint for Cardiovascular Outcomes SA Williams, R Ostroff, M Hinterberg, J Coresh, CM Ballantyne, ... Circulation 144 (Suppl_1), A11537-A11537, 2021 | | 2021 |
